The company aims to develop, manufacture, market, and distribute diagnostic solutions and technologies for monitoring biological hazards and diseases. The goal is to promote and improve human health. In this context, the company can also provide diagnostic services and develop and operate software solutions and analysis tools. The company can establish branches and subsidiaries in Switzerland and/or abroad, invest in other companies in Switzerland and/or abroad, acquire, hold, encumber, and dispose of real estate or intellectual property rights in Switzerland and/or abroad, and conduct all commercial, financial, or other transactions that are directly or indirectly related to the company's purpose. Furthermore, the company can grant loans or other financing to its direct or indirect shareholders and their direct or indirect subsidiaries, as well as to third parties, either for a fee or free of charge, and provide securities of all kinds for the liabilities of such persons or group companies, including guarantees, pledges, and fiduciary transfers of the company's assets. In addition, it can engage in or participate in liquidity balancing/net liquidity centralization (cash pooling), including periodic balance adjustments (balancing), with group companies, also without consideration, on preferential terms, interest-free, without the intention of making a profit for the company, and assuming clustering risks.
Outbound Leads by COHAGA